Advertisement

Obstetrics & Gynecology

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Research Summaries

FDA Alert
Fda alert
FDA Alert
FDA Approves First Oral Medication for Treatment of Postpartum Depression
10/04/2023

Jessica Ganga

Jessica Ganga
Following two randomized studies, the FDA has approved zuranolone for the treatment of postpartum depression in adults—the first if its kind.
10/04/2023
Research Summary
Research summary
Research Summary
Study Finds Risk of Breast Cancer Overdiagnosis Among Older Women After Screening
09/22/2023

Jessica Ganga

Jessica Ganga
In a recent study, researchers sought to determine the potential for the overdiagnosis of breast cancer after screening for women 70 years of age and older.
09/22/2023
FDA Alert
fda
FDA Alert
FDA Approves First RSV Vaccine For Pregnant Individuals
08/24/2023

Anthony Calabro, MA

Anthony Calabro, MA
Earlier this year, the FDA approved the same vaccine for the prevention of lower respiratory tract disease caused by RSV in individuals 60 years of age and older.
08/24/2023
Research Summary
Research Summary
Research Summary
Patients With Polycystic Ovarian Syndrome Have Increased Mortality Risk
08/04/2023

Jessica Ganga

Jessica Ganga
Researchers evaluated the mortality risk of patients with polycystic ovarian syndrome and the risk of death associated with disease comorbidities.
08/04/2023
FDA Alert
pills
FDA Alert
FDA Approves First Over-The-Counter, Nonprescription Daily Oral Contraceptive
07/21/2023

Jessica Ganga

Jessica Ganga
The FDA has approved the first daily oral contraceptive for the prevention of pregnancy that does not require a health care provider’s prescription.
07/21/2023
FDA Roundup
FDA
FDA Roundup
Key FDA Approvals on Novel Treatment Options for Menopausal Hot Flashes, CDI, Opioid Overdoses, and More
06/13/2023
This FDA Roundup includes an at-a-glance look at the latest FDA drug approvals in April and May, including treatment for menopausal hot flashes, Clostridioides difficile infection, suspected opioid...
06/13/2023
fda alert
fda
fda alert
FDA Approves Novel Treatment for Menopausal Hot Flashes
06/07/2023

Leigh Precopio

Leigh Precopio
The US FDA recently approved a novel treatment for moderate to severe vasomotor symptoms that are caused by menopause.
06/07/2023
Research Summary
Research Summary
Treatment of Psoriatic Arthritis in Pregnant Women Increases Risks
04/28/2023

Jessica Ganga

Jessica Ganga
The researchers evaluated the impact of antirheumatic treatment in women who are pregnant with psoriatic arthritis and how such treatment affects pregnancy outcomes.
04/28/2023
Research Summary
Research Summary
Does Vitamin D Supplementation During Pregnancy Reduce The Risk of Atopic Eczema Among Infants?
03/16/2023
In a recent clinical trial, researchers determined that mothers who took vitamin D supplements during pregnancy reduced the risk of atopic eczema in the baby’s first year.
03/16/2023
Research Summary
Research Summary
Combined Hormonal Contraceptives Lack Protection Against Musculoskeletal Conditions, Injuries
02/22/2023
A team of researchers examined the association between combined hormonal contraceptive use in women and its protection against musculoskeletal conditions and injuries.
02/22/2023